These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6433441)

  • 1. Parameters affecting the fractionation of FVIII:C activity in production of very high purity AHF concentrate.
    Törmä E; Myllylä G
    Scand J Haematol Suppl; 1984; 40():123-6. PubMed ID: 6433441
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving yield in the manufacture of factor VIII concentrates.
    Foster PR; Dickson AJ; Dickson IH
    Scand J Haematol Suppl; 1984; 40():103-10. PubMed ID: 6433439
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin and factor VIII.
    Smit Sibinga CT; Das PC
    Scand J Haematol Suppl; 1984; 40():111-22. PubMed ID: 6433440
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo effectiveness of a high-yield factor VIII concentrate prepared in a blood bank.
    Rock G; Smiley RK; Tittley P; Palmer DS
    N Engl J Med; 1984 Aug; 311(5):310-3. PubMed ID: 6429536
    [No Abstract]   [Full Text] [Related]  

  • 7. Freezing of plasma to obtain better yield of factor VIII:C.
    Carlebjörk G; Blombäck M
    Scand J Haematol Suppl; 1984; 40():127-8. PubMed ID: 6433442
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of large-scale fractionation methods. VI. An improved method for preparation of antihemophilic factor.
    Wickerhauser M; Mercer JE; Eckenrode JW
    Vox Sang; 1978; 35(1-2):18-31. PubMed ID: 664566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE; Smith JK
    Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of large-scale plasma thawing for recovery of cryoprecipitate factor VIII.
    Foster PR; Dickson AJ; McQuillan TA; Dickson IH; Keddie S; Watt JG
    Vox Sang; 1982; 42(4):180-9. PubMed ID: 6806984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave-thawed plasma for cryoprecipitate production.
    Bass H; Trenchard PM; Mustow MJ
    Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severely heated therapeutic factor VIII concentrate of high specific activity.
    Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
    Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified glycine precipitation technique for the preparation of factor VIII concentrate of high purity and high stability.
    Brodniewicz-Proba T; Beauregard D
    Vox Sang; 1987; 52(1-2):10-4. PubMed ID: 3111087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale gel filtration chromatography for the production of a solvent/detergent-treated high-purity factor VIII concentrate.
    Dengler T; Stöcker U; Kellner S; Fürst G
    Vox Sang; 1990; 58(4):257-63. PubMed ID: 1697997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII procoagulant and antigen content of antihemophilic factor (AHF) concentrates.
    Yang HC; Duffy C
    Transfusion; 1978; 18(6):747-9. PubMed ID: 726023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable degradation of factor VIII-related protein in lyophilised concentrates of antihaemophilic factor (AHF).
    Jakab T; Pflugshaupt R; Furlan M; Beck EA
    Vox Sang; 1978; 35(1-2):36-40. PubMed ID: 664567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.